ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 95 filers reported holding ADICET BIO INC in Q2 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $998,653 | -43.6% | 728,944 | 0.0% | 0.37% | -33.1% |
| Q2 2023 | $1,771,334 | -57.8% | 728,944 | 0.0% | 0.55% | -59.7% |
| Q1 2023 | $4,198,717 | +64327.1% | 728,944 | 0.0% | 1.37% | -28.0% |
| Q4 2022 | $6,517 | -99.9% | 728,944 | 0.0% | 1.90% | -37.8% |
| Q3 2022 | $10,366,000 | -2.6% | 728,944 | 0.0% | 3.05% | +12.2% |
| Q2 2022 | $10,643,000 | -26.9% | 728,944 | 0.0% | 2.72% | -1.2% |
| Q1 2022 | $14,557,000 | +14.2% | 728,944 | 0.0% | 2.75% | +89.7% |
| Q4 2021 | $12,749,000 | +123.1% | 728,944 | 0.0% | 1.45% | +189.6% |
| Q3 2021 | $5,715,000 | – | 728,944 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |